BenevolentAI Companies
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company listed on the Euronext Amsterdam stock exchange. They use their AI platform, scientific expertise, and wet-lab facilities to deliver novel drug candidates with a higher probability of clinical success. With a growing pipeline of drug programs and collaborations with AstraZeneca and other institutions, BenevolentAI is at the forefront of accelerating innovation in the biopharma industry. Headquartered in London, they also have research facilities in Cambridge (UK) and an office in New York.
Investors
Connections from
Headquarters:
London, England, United Kingdom
Founded Date:
2013
Employee Number:
251-500
Industry:
Advanced BioTech R&D
Technology:
AI R&D Pharma (DPI)